Cochrane Abstracts
Interleukin‐receptor antagonist and tumor necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interleukin‐receptor Antagonist and Tumor Necrosis Factor Inhibitors for the Primary and Secondary Prevention of Atherosclerotic Cardiovascular Diseases." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Interleukin‐receptor_antagonist_and_tumor_necrosis_factor_inhibitors_for_the_primary_and_secondary_prevention_of_atherosclerotic_cardiovascular_diseases. Accessed 12 September 2024.
Interleukin‐receptor antagonist and tumor necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Interleukin‐receptor_antagonist_and_tumor_necrosis_factor_inhibitors_for_the_primary_and_secondary_prevention_of_atherosclerotic_cardiovascular_diseases. Accessed September 12, 2024.
Interleukin‐receptor antagonist and tumor necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Interleukin‐receptor_antagonist_and_tumor_necrosis_factor_inhibitors_for_the_primary_and_secondary_prevention_of_atherosclerotic_cardiovascular_diseases
Interleukin‐receptor Antagonist and Tumor Necrosis Factor Inhibitors for the Primary and Secondary Prevention of Atherosclerotic Cardiovascular Diseases [Internet]. In: Cochrane Abstracts. [cited 2024 September 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Interleukin‐receptor_antagonist_and_tumor_necrosis_factor_inhibitors_for_the_primary_and_secondary_prevention_of_atherosclerotic_cardiovascular_diseases.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interleukin‐receptor antagonist and tumor necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases
ID - 435877
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Interleukin‐receptor_antagonist_and_tumor_necrosis_factor_inhibitors_for_the_primary_and_secondary_prevention_of_atherosclerotic_cardiovascular_diseases
DB - Evidence Central
DP - Unbound Medicine
ER -
